Nippon Shinyaku Co.,Ltd.

4516・Prime Market・Pharmaceuticals

Official website

Nippon Shinyaku Co.,Ltd.

4516・Prime Market・Pharmaceuticals

Official website

Nippon Shinyaku Co.,Ltd.4516

Reference Indicators

Market Cap

2,816¥100M

P/E (Forecast)

—

P/B

0.9x

Dividend Yield (Forecast)

3.09%

ROE

10.2%

EV/EBITDA

4.9x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	137,484	144,175	148,255	160,232	170,771
Cost of Sales	50,191	55,980	50,234	51,116	57,460
Gross Profit	87,293	88,195	98,021	109,115	113,311
SG&A Expenses	32,173	34,812	34,959	38,011	43,565
Operating Income	32,948	30,049	33,295	35,450	35,496
Pre-tax Income	33,301	30,489	33,616	36,135	36,462
Income Taxes	8,303	7,669	7,762	3,574	6,734
Net Income	24,986	22,812	25,851	32,558	29,721
EBITDA	37,536	35,090	38,318	41,465	42,125
Gross Margin	63.5%	61.2%	66.1%	68.1%	66.4%
Operating Margin	24.0%	20.8%	22.5%	22.1%	20.8%
ROA	11.4%	9.6%	9.8%	11.5%	8.6%
ROE	13.6%	11.7%	11.7%	13.2%	10.2%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医薬品	148,484	33,343	22.5%
機能食品	22,287	857	3.8%